Novo Holdings

Novo Holdings, established in 1999 and based in Copenhagen, is the asset manager for the Novo Nordisk Foundation, overseeing its wealth and investments. The company primarily focuses on the life sciences sector, investing across various stages of company development, from early-stage ventures to established firms. Novo Holdings also manages a diversified portfolio of financial investments, including equity and fixed income securities. It is recognized as a leading life science investor globally and aims to generate long-term value to support the Foundation's grant obligations for medical and scientific research. Additionally, it plays a pivotal role in the Novo Group, maintaining a significant influence over its associated companies, including Novo Nordisk and Novozymes, while ensuring compliance with the group’s shared values and management principles. Through initiatives like Novo Seeds, the firm supports early-stage applied research in Scandinavia, further solidifying its commitment to advancing health and welfare through strategic investments.

Tiba Aynechi

Partner

Nis Bjørnholt Bak

Principal

Michael Bauer

Venture Partner

Raymond Camahort

Principal at Novo Ventures

Ross Castillo

Associate

Emmanuelle Coutanceau

Partner

Kartik Dharmadhikari

Partner, Bioindustrial Investments

Nik Economopoulos

Associate

Aleks Engel

Partner, Novo Holdings (Novo Seeds) and Director, REPAIR Impact Fund

Anna Fan

Senior Partner, Life Sciences Operating Committee, Venture Investments, Venture Investments (US) Inc

Thomas Grotkjær

Investor and Principal

Kenneth Harrison Ph.D

Senior Partner, Novo Ventures

Stephen van Helden

Principal, Bioindustrial Investments, Growth Investments

Johan Hueffer

Senior Partner, Principal Investments

Noel Jee

Partner

Morten Beck Jørgensen

Managing Partner

Amit Kakar

Managing Partner and Head of Novo Holdings Asia

Navjeewan Khosla

Partner, Novo Holdings Equity Asia

Max Klement

Principal, Venture Investments

Nilesh Kumar

Partner

Abhijeet Lele

Senior Partner and Head of US Principal Investments

Jeffrey Low, MD

Principal

Heather Ludvigsen

Venture Auditor

Joe Markson

Associate

Nafise Masoumi

Associate

Peter Moldt

Partner

Jack Nielsen

Partner

Jørgen Søberg Petersen

Senior Partner, Seed Investments

Marcus REMMERS

Partner, Bioindustrial Investments

Joao Ribas

Principal, Seed Investments

Natalie Sacks

Venture Partner, Venture Investments

Naveed Siddiqi

Senior Partner, Venture Investments

Eric Snyder

Partner

Jim Trenkle

Partner, Venture Investments

Matthias Vinther

Senior Associate

Past deals in Hospital

Doctor Anywhere

Series C in 2021
Doctor Anywhere Pte Ltd is a Singapore-based telehealth company that provides an online platform for health and wellness solutions. Established in 2016, the company specializes in video consultations, allowing patients to consult with licensed and registered doctors for various medical needs. Its digital platform offers on-demand healthcare services that are designed to be simple, seamless, and convenient, catering to the evolving lifestyle preferences of users. By integrating a range of health services, Doctor Anywhere enables patients to receive appropriate diagnoses, medication, and e-prescriptions, facilitating access to healthcare anytime and anywhere. The company aims to improve health outcomes through technology, addressing modern healthcare challenges and enhancing the overall patient experience.

Halodoc

Series C in 2021
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, facilitating real-time online consultations. The platform also allows patients to order laboratory tests that can be conducted at home and helps them locate nearby hospitals and clinics. Additionally, HaloDoc provides access to licensed medical laboratory services and a medical delivery service known as ApotikAntar, further enhancing the convenience and accessibility of healthcare for its users.

MDLive

Venture Round in 2018
Founded in 2006, MDLive is a telehealth provider that offers online and on-demand healthcare services. The company connects patients with board-certified doctors through phone, video, and mobile applications, facilitating access to medical care without the need for in-person visits. Its cloud-based platform allows healthcare professionals and institutions to conduct virtual consultations, helping to ensure safe and efficient patient care while reducing the costs associated with emergency room and urgent care visits for non-emergency issues. MDLive serves a diverse range of clients, including hospitals, employers, payers, and physician practice groups, thereby enhancing the overall healthcare delivery system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.